Alembic Pharmaceuticals Ltd leads losers in A group - Business Standard
| APLLTD Stock | 1,081 7.20 0.66% |
About 62% of Alembic Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Alembic Pharmaceuticals Limited stock suggests that many investors are alarmed at this time. The current market sentiment, together with Alembic Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Alembic Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Alembic |
Alembic Pharmaceuticals Ltd leads losers in A group Business Standard
Read at news.google.com
 |
Alembic Pharmaceuticals Fundamental Analysis
We analyze Alembic Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alembic Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alembic Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Alembic Pharmaceuticals is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Alembic Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alembic Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Alembic Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Alembic Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Alembic Pharmaceuticals Related Equities
Complementary Tools for Alembic Stock analysis
When running Alembic Pharmaceuticals' price analysis, check to measure Alembic Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alembic Pharmaceuticals is operating at the current time. Most of Alembic Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Alembic Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alembic Pharmaceuticals' price. Additionally, you may evaluate how the addition of Alembic Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |